U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915102) titled 'CAR-T Therapy: Safety, Efficacy, and Immune-Escape Mechanisms' on Oct. 19.
Brief Summary: The study is a biological, drug-related, non-interventional observational study with both retrospective and prospective components.
No experimental diagnostic procedures, investigational medicinal products, or medical devices will be used, and samples will be collected as part of routine clinical practice.
Study Start Date: Feb. 02, 2023
Study Type: OBSERVATIONAL
Condition:
CAR-T Cell Therapy
Bispecific Antibodies
Recruitment Status: RECRUITING
Sponsor: Ciceri Fabio
Information provided by (Responsible Party): Ciceri Fabio, IRCCS San Raf...